APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM NEW
Total 13F shares
2,943,834
Share change
+30,456
Total reported value
$89,749,000
Price per share
$30.52
Number of holders
32
Value change
+$726,907
Number of buys
15
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q1 2021

As of 31 Mar 2021, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,943,834 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., Balyasny Asset Management LLC, BlackRock Inc., Ghost Tree Capital, LLC, Anson Funds Management LP, and TWO SIGMA INVESTMENTS, LP. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.